#USA #New York #Life Sciences #AVANT BIO #Ole Henrik Bang-Andreasen

Ole Henrik Bang-Andreasen Promoted to Partner at AVANT BIO

AVANT BIO, a renowned growth equity firm at the forefront of therapeutic-enabling technologies, has officially announced the promotion of Ole Henrik Bang-Andreasen to the position of Partner. This strategic move underscores Ole's invaluable contributions to the firm's investment strategies, support for its portfolio companies, and overall growth within vital life sciences markets.

Since joining AVANT BIO, Ole has significantly impacted the firm by spearheading investment efforts, identifying and nurturing innovative companies and technologies, and supporting the expansion of AVANT BIO’s portfolio. His role in strengthening the firm's presence in Europe has been particularly noteworthy, allowing AVANT BIO to tap into the burgeoning life sciences innovation ecosystem in the region.

Expressing his enthusiasm for the future, Ole said, "I am looking forward to continuing the work on making AVANT BIO the premier financier of growth-stage Life Science Industrials companies across the globe, and to continue building the AVANT BIO brand in this exciting sector." His dedication to the mission of AVANT BIO is evident through his strategic vision and commitment to excellence.

Ole’s impressive credentials reflect a deep investment acumen, a global perspective, and extensive experience in fostering high-growth companies across various therapeutic enabling technology sectors. He currently serves on the boards of three AVANT BIO portfolio companies: PL BioScience, Abbelight, and PathPresenter. In these capacities, he plays a key role in evaluating emerging opportunities, cultivating relationships with founders and investors, and supporting the development of portfolio companies.

With a comprehensive background in investing within Life Science markets over the past decade, Ole has navigated both public and private markets, from the formation of companies through to their IPO processes. Before his tenure at AVANT BIO, he built an impressive career at Tower House Partners, ABG Sundal Collier, and Game Creek Capital. His past experiences have been complemented by a commitment to teamwork and leadership, demonstrated through his roles as a National Team Rower for Norway, as well as Captain of the Northeastern University Men's Rowing Team, and as a professional cyclist for Trinity Racing.

Daniella Kranjac, the Founding General Partner at AVANT BIO, has praised Ole's contributions, stating, "Ole joined AVANT BIO ahead of our Fund II launch and has been an integral part of our investment team and our strategy development. Ole has demonstrated exceptional leadership in both day-to-day and strategic initiatives and has made significant contributions to the growth and scaling of our firm." Ole's promotional achievement reflects his hard work and strategic insight, highlighting the firm's confidence in his abilities to drive AVANT BIO's mission forward.

AVANT BIO continues to build its team and reinforce its leadership position at the cutting-edge of therapeutic enabling technologies. By leveraging the diverse expertise of its team, the firm aims to shape the future of Life Sciences, TechBio, and HealthTech.

About AVANT BIO

AVANT BIO LLC is a dedicated growth equity firm focused on investing in therapeutic-enabling technologies that influence the development, manufacturing, and delivery of tomorrow's therapies. With a keen investment focus on accelerating innovation across various stages of company development, AVANT BIO is committed to realizing the total potential of therapeutic enabling technologies, TechBio, and HealthTech. For more information, including partnership opportunities, visit www.avant.bio. Follow AVANT BIO on LinkedIn for up-to-date news and insights into the industry.